Skip to main content
Sumitomo Pharma Co., Ltd. logo

Sumitomo Pharma Co., Ltd. — Investor Relations & Filings

Ticker · 4506 ISIN · JP3495000006 LEI · 529900D60UKVYLJ2OJ79 T Manufacturing
Open in API
Filings indexed 94 across all filing types
Latest filing 2022-08-03 Report Publication Anno…
Country JP Japan
Listing T 4506

About Sumitomo Pharma Co., Ltd.

https://www.sumitomo-pharma.com/

Sumitomo Pharma Co., Ltd. is a research and development-driven pharmaceutical company focused on creating innovative pharmaceuticals and healthcare solutions. The company's primary therapeutic areas are Psychiatry & Neurology and Oncology, with additional activities in diabetes, rare diseases, and women's health. A key aspect of its R&D strategy is the integration of established expertise in small molecule drug discovery with pioneering modalities such as regenerative medicine and cell therapy. The company's mission is to translate scientific innovation into real-world solutions to contribute to the betterment of healthcare and fuller lives for people worldwide, with a strategic business focus on Japan and the United States.

Recent filings

Filing Released Lang Actions
確認書
Report Publication Announcement Classification · 100% confidence The document is a 'Confirmation Letter' (Kakunin-sho) filed under the Financial Instruments and Exchange Act in Japan. It specifically confirms the accuracy of the contents of the Quarterly Report (Shihanki Hokokusho) for the first quarter of the 203rd fiscal period. Since this is a regulatory filing confirming the accuracy of a report rather than the quarterly report itself, and it does not fit into the other specific categories like 10-K or IR, it is classified as a Regulatory Filing.
2022-08-03 Japanese
四半期報告書－第203期第1四半期(令和4年4月1日－令和4年6月30日)
Interim / Quarterly Report Classification · 100% confidence The document is a Japanese 'Quarterly Report' (四半期報告書) filed under the Financial Instruments and Exchange Act. It contains detailed financial statements, management analysis (MD&A), and segment performance data for the first quarter of the 203rd fiscal period (April 1, 2022, to June 30, 2022). As it is a comprehensive financial report for a period shorter than a full fiscal year, it falls under the 'Interim / Quarterly Report' category. Q1 2023
2022-08-03 Japanese
内部統制報告書－第202期(令和3年4月1日－令和4年3月31日)
Audit Report / Information Classification · 98% confidence The document is an 'Internal Control Report' (内部統制報告書) filed under the Financial Instruments and Exchange Act in Japan. It details the company's framework, scope, and evaluation results regarding internal controls over financial reporting. This type of document is a standalone regulatory filing concerning audit and internal control standards, which fits the 'Audit Report / Information' (AR) category. FY 2022
2022-06-23 Japanese
確認書
Regulatory Filings Classification · 95% confidence The document is a 'Confirmation Letter' (Kakunin-sho) filed under the Financial Instruments and Exchange Act, Article 24-4-2, Paragraph 1. This is a mandatory document in Japan that accompanies the Annual Securities Report (Yukashoken Hokokusho) to confirm the accuracy of the report's contents. Since it is a regulatory filing required by law to accompany the annual report and does not fit into the other specific categories like 10-K or IR, it is classified as a Regulatory Filing (RNS).
2022-06-23 Japanese
有価証券報告書－第202期(令和3年4月1日－令和4年3月31日)
Annual Report Classification · 100% confidence The document is a Japanese 'Yuka Shoken Hokokusho' (Securities Report), which is the Japanese equivalent of a 10-K annual report. It contains a formal header identifying it as a report submitted to the Kanto Local Finance Bureau under the Financial Instruments and Exchange Act, covering the fiscal year from April 1, 2021, to March 31, 2022. The document includes extensive XBRL-like metadata and financial reporting structures, confirming it is the full annual financial filing rather than an announcement or summary. FY 2022
2022-06-23 Japanese
四半期報告書－第202期第3四半期(令和3年10月1日－令和3年12月31日)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (四半期報告書) filed with the Kanto Local Finance Bureau in Japan. It contains detailed financial statements, management analysis of financial conditions and results of operations (MDA), and segment performance data for the third quarter of the 2022 fiscal year (covering the period from October 1, 2021, to December 31, 2021). As it is a comprehensive financial report for a period shorter than a full fiscal year containing substantive financial data, it is classified as an Interim/Quarterly Report. 9M 2022
2022-02-03 Japanese

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.